相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice
Shiguang Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
How fibroblast growth factor 23 works
Shiguang Liu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets
Erik A. Imel et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis
Bettina Lorenz-Depiereux et al.
NATURE GENETICS (2006)
Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism
Jian Q. Feng et al.
NATURE GENETICS (2006)
Pathogenic role of Fgf23 in Hyp mice
Shiguang Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Dentin matrix protein 1 induces cytodifferentiation of dental pulp stem cells into odontoblasts
A Almushayt et al.
GENE THERAPY (2006)
Extracellular matrix-mediated signaling by dentin phosphophoryn involves activation of the smad pathway independent of bone morphogenetic protein
JA Jadlowiec et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Dentin matrix protein 1 enhances invasion potential of colon cancer cells by bridging matrix metalloproteinase-9 to integrins and CD44
A Karadag et al.
CANCER RESEARCH (2005)
Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23
XJ Yu et al.
ENDOCRINOLOGY (2005)
Role of matrix extracellular phosphoglycoprotein in the pathogenesis of α-linked hypophosphatemia
SG Liu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone
M Murshed et al.
GENES & DEVELOPMENT (2005)
Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed
T Larsson et al.
ENDOCRINOLOGY (2005)
In vitro effects of dentin matrix protein-1 on hydroxyapatite formation provide insights into in vivo functions
PH Tartaix et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Dentin matrix protein 1 immobilized on type I collagen fibrils facilitates apatite deposition in vitro
G He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa
T Shimada et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism
T Shimada et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
FGF23 is processed by proprotein convertases but not by PHEX
A Beret-Pagès et al.
BONE (2004)
Transgenic mice expressing fibroblast growth factor 23 under the control of the α1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis
T Larsson et al.
ENDOCRINOLOGY (2004)
Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice
D Sitara et al.
MATRIX BIOLOGY (2004)
Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders
XY Bai et al.
ENDOCRINOLOGY (2004)
The dentin matrix protein 1 (Dmp1) is specifically expressed in mineralized, but not soft, tissues during development
JQ Feng et al.
JOURNAL OF DENTAL RESEARCH (2003)
Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX
SG Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Serum FGF23 levels in normal and disordered phosphorus homeostasis
TJ Weber et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Dual functional roles of dentin matrix protein 1 -: Implications in biomineralization and gene transcription by activation of intracellular Ca2+ store
K Narayanan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency
XY Bai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia
Y Yamazaki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Three SIBLINGs (small integrin-binding ligand, N-linked glycoproteins) enhance factor H's cofactor activity enabling MCP-like cellular evasion of complement-mediated attack
A Jain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23
KE White et al.
KIDNEY INTERNATIONAL (2001)
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
KE White et al.
NATURE GENETICS (2000)
分享论文
